about
Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancerA prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancerThe utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratificationSpleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.Thromboembolism in lung cancer - an area of urgent unmet need.Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.The evolving role of molecular imaging in non-small cell lung cancer radiotherapy.PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer.Acute radiation oesophagitis associated with 2-deoxy-2-[18F]fluoro-d-glucose uptake on positron emission tomography/CT during chemo-radiation therapy in patients with non-small-cell lung cancer.Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy.Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.Motivations to nurse: an exploration of what motivates students in Pacific Island countries to enter nursing.Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic Non-Small Cell Lung Carcinoma (NSCLC).The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study.Mobilization of viable tumor cells into the circulation during radiation therapy.Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation.Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma.Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.Radiation therapy-induced metastasis: radiobiology and clinical implications.Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning.Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol.Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse SurInfluence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague.Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis.Treatment Planning for Radiation Therapy.Radiotherapy for Non-Small Cell Lung Cancer Induces DNA Damage Response in Both Irradiated and Out-of-field Normal Tissues.High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer.Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modelingRandomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Lung CancerAbscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung CancerImpact of PET on Radiation Therapy PlanningDynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer
P50
Q34041796-67137DA8-2CC7-43D1-89D3-133DB8C73A80Q34318535-BC3D518C-16AF-49CF-A31C-32A943F1768FQ35093230-FE2372A5-2713-4B9F-8F5A-611A15E4A0F1Q35849774-E9916D86-639A-4DA0-81A4-61F890EBDA9EQ38113466-601200A2-A5FF-4DF3-A958-524277C74D37Q38200199-1400DB8E-77B8-462D-B1FE-3AAE54FB0378Q38362240-EBC7BB73-49E2-480D-AE20-D9862D191C00Q38378135-C39FA9C5-F266-47B3-AB48-75681FC300EFQ38419113-B831E659-DD10-4CA0-B903-5CC65ED99A72Q38544547-87558938-417D-479A-9DF5-B5F618B2ADA5Q38669760-0F1F218C-EE67-414A-84D3-A2598CB95997Q38671608-E967BF1C-A2F8-4AA7-AE61-5559F2F090B2Q38701907-AEDB2F85-E0A4-4020-AFBA-A5C4068ED44DQ38766127-03FE200E-9E70-4D33-A6C8-3E9525D5812AQ38934490-243F9B48-E5C2-4323-9F85-5120BA2DB4F7Q38974148-FDE3FB46-5B89-4D66-980D-D1B83FADBD6DQ39339418-7A27F815-A507-469A-AE4C-B5BA2A404706Q40185703-5CBA8CDD-BCC5-4BAA-874B-E493885F66BAQ40925756-8FB4A556-2050-453C-985A-8838DFE4CBCBQ42237728-4A4458BD-0978-4107-AFF6-AAAC5291BDCCQ43089571-452F3394-0C70-437D-8990-AF0432DAE528Q45120740-40E38125-4691-4460-B7A1-923CB3F1BD42Q47138202-BE9EE2A6-78B8-4C9C-91DD-0EB6DA0549FAQ47438065-2AA1C97F-DBE9-4E05-BE9F-43F168663659Q48006804-162B5D48-910A-483E-B59C-598F14367476Q48763632-F49635EA-B326-4004-8E3A-1A99AFBF8EF2Q50074851-05EDD2F4-A8C7-49AC-8556-DEEC332F806AQ51103075-48ABEC26-33E4-40AC-906B-124C10B73FCBQ51644443-DF0178DC-AF49-49D5-BBBD-FD9741B89D6AQ52371201-863B044F-060F-4D22-8A5A-6CE49A2B0EA6Q52744119-5EAD5252-9C17-48B4-B85D-48AE335565A7Q52865858-A090E584-23C5-416E-BA5A-3F7EB614BC40Q53011762-6D8090B3-FC36-47E1-9366-D12E0F88E8F5Q53047368-0EED47A4-6E70-4273-96A3-DD53D5D9F102Q57154425-C27D63CF-9008-46CA-8766-79361C335BBDQ57284586-DCB383BC-C686-4663-8D0E-B31FC85F0629Q57758728-C5F24A5E-76A7-4882-9C0F-847DC0578CAFQ57758819-C7E94EE6-0305-4F4F-9CA6-2DE75D21858EQ57758921-77783775-30D6-4092-AAD0-1D5DC33F06BEQ61800538-5789B8D7-C2CF-4A5C-BAB3-F7A4F2FFF200
P50
description
investigador
@es
researcher
@en
name
Michael MacManus
@en
type
label
Michael MacManus
@en
prefLabel
Michael MacManus
@en
P31
P496
0000-0002-0900-5815